RCEL
AVITA MedicalDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade D from latest DB weights. Momentum 99.8 / Value 40.6
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
100
Value
41
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $12.99
Why
Momentum100 · Δ7d +0.3
Value41 · Δ7d -0.0
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
100
15% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+0.4
Value
41
85% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 99.8 / Value 40.6
Fundamentals (TTM)As of 2026-10-26
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$469.47M
Beta
1.77
Shares Out
30.49M
P/E (TTM) · Derived
-8.8
P/S (TTM)
1.46
P/FCF (TTM) · Derived
-18.37
Rev YoY
+17.8%
EPS YoY
-33.8%
Gross Margin
+81.6%
Op Margin
-46.6%
Net Debt
$27.86M
Current Ratio
0.41
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data